Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OXYQUINOLINE: 122 Adverse Event Reports & Safety Profile

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit
122
Total FAERS Reports
65 (53.3%)
Deaths Reported
79
Hospitalizations
122
As Primary/Secondary Suspect
80
Life-Threatening
32
Disabilities
CooperSurgical, Inc.
Manufacturer

Active Ingredient: OXYQUINOLINE SULFATE · Route: VAGINAL · Manufacturer: CooperSurgical, Inc. · HUMAN PRESCRIPTION DRUG · FDA Label: Available

First Report: 20130207 · Latest Report: 20250228

What Are the Most Common OXYQUINOLINE Side Effects?

#1 Most Reported
Drug ineffective
96 reports (78.7%)
#2 Most Reported
Pain
81 reports (66.4%)
#3 Most Reported
Joint swelling
70 reports (57.4%)

All OXYQUINOLINE Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Drug ineffective 96 78.7% 44 58
Pain 81 66.4% 45 55
Joint swelling 70 57.4% 48 60
Pulmonary embolism 62 50.8% 34 43
Rheumatoid arthritis 59 48.4% 36 42
Drug intolerance 57 46.7% 50 55
Stomatitis 56 45.9% 52 55
C-reactive protein increased 55 45.1% 45 49
Urticaria 55 45.1% 52 55
Apparent death 53 43.4% 34 43
Deep vein thrombosis 53 43.4% 34 43
Diverticulitis 53 43.4% 34 43
Renal failure 53 43.4% 34 43
Intentional product use issue 52 42.6% 48 52
Arthropathy 51 41.8% 46 51
Off label use 51 41.8% 39 47
Drug hypersensitivity 50 41.0% 42 46
Red blood cell sedimentation rate increased 50 41.0% 46 50
C-reactive protein abnormal 46 37.7% 42 46
Contraindicated product administered 46 37.7% 44 45

Who Reports OXYQUINOLINE Side Effects? Age & Gender Data

Gender: 57.6% female, 42.4% male. Average age: 51.4 years. Most reports from: CA. View detailed demographics →

Is OXYQUINOLINE Getting Safer? Reports by Year

YearReportsDeathsHosp.
2013 1 1 1
2020 1 0 1
2021 1 0 0
2025 1 0 0

View full timeline →

What Is OXYQUINOLINE Used For?

IndicationReports
Rheumatoid arthritis 67
Systemic lupus erythematosus 48
Product used for unknown indication 41

OXYQUINOLINE vs Alternatives: Which Is Safer?

OXYQUINOLINE vs OXYTOCIN OXYQUINOLINE vs OXYTROL FOR WOMEN OXYQUINOLINE vs OZANIMOD OXYQUINOLINE vs PACLITAXEL OXYQUINOLINE vs PACRITINIB OXYQUINOLINE vs PALBOCICLIB OXYQUINOLINE vs PALIPERIDONE OXYQUINOLINE vs PALIVIZUMAB OXYQUINOLINE vs PALONOSETRON OXYQUINOLINE vs PAMIDRONATE

Official FDA Label for OXYQUINOLINE

Official prescribing information from the FDA-approved drug label.

Drug Description

P URPOSE OF TRIMO-SAN 1. To help restore and maintain normal vaginal acidity. 2. To coat walls of vagina with a lubricating film that may help reduce odor-causing bacteria, since bacteria can flourish in abnormal vaginal pH.

Warnings

W ARNING: Chemicals in various preparations can interact with the pessary material resulting in discoloration or deterioration of the pessary. TRIMO-SAN does not have a deleterious effect on any Milex pessary. Testing should be performed before using any other vaginal preparation with a pessary unless specifically prescribed by your healthcare professional.